Загрузка...
Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
BACKGROUND: Apixaban was shown to be superior to adjusted-dose warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation (AF) and at least one additional risk factor for stroke, and associated with reduced rates of hemorrhage. We sought to determine the cost-effectivene...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3467203/ https://ncbi.nlm.nih.gov/pubmed/23056642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047473 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|